A prominent life science-focused developer is stretching its Bay Area footprint even further after closing on a $156 million Silicon Valley portfolio it plans to transform into a new biotech hub.
A prominent life science-focused developer is stretching its Bay Area footprint even further after closing on a $156 million Silicon Valley portfolio it plans to transform into a new biotech hub.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In